A Catastrophic-Onset Longitudinal Myelitis Accompanied by Bilateral Internuclear Ophthalmoplegia in a Patient with Systemic Lupus Erythematosus by Rheu, Chang-Woo et al.
INTRODUCTION
Transverse myelitis (TM) is a rare neurological complication
in patients with systemic lupus erythematosus (SLE) (1-3).
Moreover TM involving the entire spinal cord longitudinally
has only been reported in only a few SLE cases (4, 5). In par-
ticular, the medulla oblongata involvement was reported in
two cases only (6, 7). Internuclear ophthalmoplegia (INO)
presents either as an isolated condition or as one associated
with other neurological symptoms (8). INO is an uncommon
neurological complication in SLE, and several cases of INO
associated with SLE have been observed (9). In particular,
the case of TM longitudinally involved accompanied by bilat-
eral INO has never been reported in patients with SLE. Steroid
therapy seems effective in improving INO (9), but the out-
come of TM involving the entire spinal cord longitudinally
is unfavorable despite an aggressive treatment with high dose
of steroid and cyclophosphamide in several cases (4, 5). Here,
we describe a patient who was diagnosed as having catastro-
phic-onset longitudinal myelitis involving the entire spinal
cord accompanied by bilateral INO associated with systemic
lupus erythematosus.
CASE REPORT
A 28-yr-old woman was hospitalized due to a cough, coryza,
fatigue, a mild headache, and low-grade fever for three days.
Four years ago, she was diagnosed as type IV lupus nephri-
tis by renal biopsy, and had been treated with methylpred-
nisolone pulses and monthly intravenous (i.v.) cyclophopha-
mide pulses for two years. She experienced complete remis-
sion and had subsequently been maintained with 300 mg of
hydroxychloroquine and 7.5 mg of prednisolone daily. On
admission, her vital signs and neurologic examination were
normal. Laboratory data showed a white blood cell count of
3,200/ L, hemoglobin of 10.1 g/dL, and a platelet count of
235,000/ L. Her erythrocyte sedimentation rate (ESR) was
80 mm/hr (normal <20). Urine analysis, serum electrolytes
and creatinine, liver and thyroid function test, prothrombin
time, and activated partial prothrombin time were normal.
Her antinuclear antibody (ANA) titer was 1:320 (homoge-
nous pattern) and anti-double-stranded DNA antibody level
was over 107 IU/mL (normal 0-7). Serum complement lev-
els were C3 of 27.2 mg/dL (normal 65-125) and C4 of 7.23
mg/dL (normal 12-43), which were lower than those of pre-
vious tests. Anticardiolipin antibodies, lupus anticoagulant,
anti SSA/SSB antibodies, anti Sm and RNP antibodies, and
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A Catastrophic-Onset Longitudinal Myelitis Accompanied by Bilateral
Internuclear Ophthalmoplegia in a Patient with Systemic Lupus 
Erythematosus
Transverse myelitis (TM) extending from midbrain to the entire spinal cord accom-
panied by internuclear ophthalmoplegia is extremely rare but cause serious cen-
tral nervous system complications in patients with systemic lupus erythematosus.
We report a case of a 28-yr-old woman with TM extending from the midbrain to the
conus medullaris longitudinally and internuclear ophthalmoplegia associated with
systemic lupus erythematosus. Her neurological symptoms had an abrupt catas-
trophic onset and rapidly progressed to respiratory failure within 24 hr. Bilateral
internuclear ophthalmoplegia was also followed by TM. Brain MR images showed
definite brainstem lesions, which were deeply associated with internuclear ophthal-
moplegia, and diffuse signal changes in the whole spinal cord, medulla, pons and
midbrain. Clinical improvement of her ophthalmoplegia and of neurological dysfunc-
tion of the upper extremities was noted after prompt and aggressive treatment with
intravenous pulsed methylprednisolone and cyclophosphamide. However, the neu-
rological dysfunction of the lower limbs and bladder and colon paralysis were almost
unchanged until six months passed.
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the Venereal Disease Research Laboratory (VDRL) test were
all negative. Plain radiography examination revealed pansi-
nusitis of both maxillary and fronto-ethmoidal sinuses. She was
initially treated with antibiotics and 20 mg of prednisolone
per day under the diagnosis of sinusitis and flares of lupus. 
On the third day of the admission, her previous symptoms
became aggravated and she developed a severe headache, nau-
sea, and vomiting. Aspirated cerebrospinal fluid (CSF) con-
tained leukocytes of 54/HPF (neutrophils 87%, lymphocytes
13%), protein of 49.1 mg/dL (15-45), and glucose of 31 mg/
dL (50-75). Subsequently, the Gram stain and culture of CSF
were found to be negative and aseptic meningitis was diag-
nosed. 
On the fourth day of the admission, the patient presented
with an abrupt onset of nystagmus, horizontal diplopia, and
mild tingling sensation of the anterolateral aspect of the left
Fig. 1. (A) Left lateral gaze and (B) Right lateral gaze. This patient
shows marked bilateral limitation of adduction not crossing mid-
line (arrows), but no limitation of abduction, elevation and depres-
sion in eyeball movement.
A
B
Fig. 2. (A) Sagittal T2-
weighted MR image of
the brainstem and the
spinal cord before treat-
ment. This image shows
generalized multifocal
high signal intensities in-
volving midbrain, pons,
medulla and whole spi-
nal cord longitudinally.
(B) This T2-weighted MR
image after one month
shows decrease in the
previous high signal in-
tensities in the midbrain,
pons, medulla, and cer-
vical spinal cord. However, more increased high signal intensities
and distorted conus medullaris are seen in the thoracic and lum-
bar spinal cord.
A B
Fig. 3. (A) T2-weighted brain MR image before treatment. This image shows nodular high signal intensity in periaqueductal region of the
midbrain (arrow). (B) This follow up image after treatment shows decrease in the previous high signal intensities in periaqueductal region
of the midbrain (arrow).
A Bthigh. An ophthalmic examination showed medial gaze dis-
turbance of the both eyeballs (Fig. 1), but reduction of visu-
al power, visual field defect, and optic disc abnormality were
not detected. We observed bilateral adduction weakness and
concomitant abducting nystagmus with intact vertical eye-
ball movement. Thus, she was diagnosed as having bilateral
INO. In addition, a weakness of both legs and voiding diffi-
culty developed. The sensory deficit was consistent with below
T10 level, and bladder catheterization yielded 800 mL of
residual urine. After 12 hr, flaccid paralysis developed in both
upper and lower extremities. The sensory deficit was consis-
tent with below T4 level, and bladder and colon paralysis
persisted. An MRI scan of the brain and whole spine showed
a diffuse swelling and high signal intensities involving the
whole spinal cord, pons, and medulla oblongata (Fig. 2A).
Bilateral high signal intensities in T2-weighted image were
pronounced in the lower midbrain, pons, medulla oblonga-
ta, and periaqueductal region (Fig. 3A). With a diagnosis of
acute catastrophic-onset longitudinal myelitis, aggressive
treatment with i.v. pulsed methylprednisolone was started
immediately. Nonetheless, vigorous dyspnea occurred sever-
al hours later and mechanical respiratory support was per-
formed due to respiratory failure and stuporous mental state.
Intravenous pulsed methylprednisolone was given for 5 days
and i.v. pulsed cyclophosphamide was added in the intensive
care unit. Her mental status and respiratory function were
slowly improved and returned to normal. 
On the ninth day of the admission, motor and sensory func-
tions of the upper extremities were restored to the T10 level,
and motor function of both eyeballs was recovered. However,
the neurological dysfunction of the lower limbs, and bladder
and colon paralysis were almost unchanged. Follow up MR
images, which were taken one month later, showed decreased
high signal intensity of the cervical spinal cord and brainstem.
However, remnant and worsened abnormal changes in the
thoracic spinal cord extending to the conus medullaris were
identified (Fig. 2B, 3B). The patient was discharged to a reha-
bilitation clinic and six month later her neurological deficit
was unchanged despite monthly i.v. pulsed cyclophosphamide
and 20 mg prednisolone a day.
DISCUSSION 
TM is a rare neurological manifestation, but causes serious
complication in patients with SLE (1-3). Previous reports have
indicated about 1-2% prevalence. (10). Moreover, a small num-
ber of reports concern MRI-depicted longitudinal myelitis
of the entire or the greater part of the spinal cord in SLE (4,
5). Deodhar et al. (11) reported the case of a patient with con-
tinuous involvement of the spinal cord from C3 to T2 and
from T7 to the conus medullaris. This is the first report of a
longitudinal myelitis. Especially, two cases of medulla oblon-
gata involvement have been reported (6, 7). In the case of our
patient, the TM extended from the midbrain to the conus
medullaris, which has never been reported previously. 
This patient’s neurological symptoms showed an abrupt
catastrophic onset, and rapidly progressed to respiratory fail-
ure within several days. TM with an acute catastrophic onset
is rarer than acute or subacute onset in SLE (2, 3). Study of
Ropper and Poskanzer (3) suggested that three distinct types
of onset occur in TM; the largest group has ascending pares-
thesia at onset, usually with a course that evolves over one
to fourteen days; the smaller group has an evolving syndrome
over ten days to four weeks with a stuttering course; another
group coming on suddenly and evolving over several hours.
In particular, the last group showing hyperacute and catas-
trophic onset followed by the development of a ‘spinal shock
syndrome’ tends to have a poor prognosis. Thus, our patient’s
case represents the most severe form of the disease. 
One of the focal neurological manifestations of SLE is INO.
It is defined as a lesion of the medial longitudinal fascicle,
which connects the nucleus of the VI cranial nerve pair with
the contralateral III pair during horizontal movement (8). INO
presents almost invariably during periods of SLE activity and
is either isolated or, more often, is associated with other neu-
rological symptoms. However, its prevalence in SLE is low
and only a few cases of bilateral INO have been reported (9).
This is the first case in the literature of bilateral INO accom-
panied by TM. MRI has shown brainstem lesions in only two
of the literature-reported INO patients (12, 13). Our patient’s
MR images showed definite brainstem lesions, which were
deeply associated with internuclear ophthalmoplegia. Usu-
ally, treatment with high-dose corticosteroids has been found
to resolve the eye derangement in INO (9). This treatment
was also found to be effective with our patient.
Three types of pathological changes have been reported in
SLE-related myelopathy (2). The first is an extensive spinal
cord softening limited to a specific cord level, accompanied by
vascular alterations ranging from perivasculitis to thrombosis.
The second is a large subdural hematoma in the spinal cord
without vasculopathy. The third, the most common change,
is a peripheral white matter degeneration, often at multiple
spinal cord levels, which is called subpial leukomyelopathy.
Pathogenic mechanisms of TM in SLE include vascular injuries
secondary to immune-complex mediated vasculitis, non-vas-
cular injuries due to antineuronal antibodies, and white mat-
ter degeneration (14). In addition, longitudinal myelitis might
be related to either a vascular occlusive phenomena of the
spinal cord associated with antiphospholipid antibody (aPL)
or to a direct interaction between aPL and spinal cord phos-
pholipids (15). Though we did not perform assays for antineu-
ronal and antiribosomal P antibodies, it is quite likely that
humoral factors other than aPL were implicated in the patho-
genesis of the TM in this case because of negative results of
aPL. Further research will be necessary to delineate the pre-
cise relationship between these laboratory parameters and
spinal cord disease in TM. 
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The outcome of TM associated with SLE is favorable (16). It
has been postulated that aggressive treatment early in the
course of the disease is crucial for a favorable response (17).
Therapy with i.v. pulsed cyclophosphamide, when given in
conjunction with high dose corticosteroids, has been success-
ful in TM (18). However, Tellez-Zenteno et al. (5) indicated
that aggressive treatment with high dose corticosteroids and
cyclophosphamide can not prove useful in the treatment of
longitudinal myelitis, and found that the outcome is unfa-
vorable in most cases. Also, Ropper and Poskanzer (3) empha-
sized that a hyperacute, catastrophic onset with the develop-
ment of a total neurological deficit within 12 hr results in a
poor outcome. Our patient received prompt treatment with
corticosteroid and i.v. pulsed cyclophosphamide resulting in
the restoration of a respiratory failure and the partial return
of function of the upper extremities. However, neurological
deficit below the T10 level, and bladder and colon paralysis
persisted for six months. 
In summary, this patient has the following characteristics.
First, this is the first case of transverse myelitis involving the
entire brain stem and spinal cord. The lesions are continuous
from the midbrain to the conus medullaris longitudinally.
Second, this patient’s severe neurological symptoms had an
abrupt catastrophic onset and rapidly progressed to respira-
tory failure within several days. Third, this patient is the first
reported case of bilateral INO accompanied by transverse
myelitis involving entire spinal cord longitudinally, and her
MRI showed definite brainstem lesions deeply associated with
INO. 
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